Geneos Wealth Management Inc. Purchases 511 Shares of Encompass Health Corporation $EHC

Geneos Wealth Management Inc. lifted its position in Encompass Health Corporation (NYSE:EHC) by 159.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 831 shares of the company’s stock after purchasing an additional 511 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Encompass Health were worth $84,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Nuveen LLC bought a new stake in Encompass Health during the 1st quarter worth approximately $50,665,000. T. Rowe Price Investment Management Inc. grew its holdings in shares of Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after purchasing an additional 424,691 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Encompass Health by 78.6% during the first quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock worth $73,243,000 after purchasing an additional 318,251 shares during the last quarter. Invesco Ltd. grew its holdings in Encompass Health by 5.1% during the 1st quarter. Invesco Ltd. now owns 5,818,783 shares of the company’s stock worth $589,326,000 after acquiring an additional 282,532 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in Encompass Health by 12,207.6% during the 1st quarter. GAMMA Investing LLC now owns 239,628 shares of the company’s stock worth $24,270,000 after acquiring an additional 237,681 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 2.00% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on EHC shares. Bank of America increased their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Stephens raised shares of Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. Wall Street Zen lowered Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. KeyCorp increased their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, Truist Financial raised their price target on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $138.43.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $124.23 on Thursday. The firm has a market cap of $12.51 billion, a price-to-earnings ratio of 24.31, a price-to-earnings-growth ratio of 2.17 and a beta of 0.92. The stock’s 50-day moving average is $117.86 and its 200-day moving average is $113.26. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.15. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. The firm had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business’s quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 annualized dividend and a yield of 0.6%. Encompass Health’s payout ratio is presently 13.31%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.